Clinical Trials Browser

Completed × peginterferon alfa-2b × Genitourinary × Clear all

NCT02089685 2022-09-13

MK-3475-029

Phase 1/2 Completed

295 enrolled 25 charts

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT00045279 2013-06-05

PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms